Reviva Pharmaceuticals Holdings, Inc. Public Float
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Public Float of $21.40 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $21.40M.
- 2024-06-28: Entity Public Float $31.80M.
- 2023-12-31: Entity Public Float $103.70M.
- 2022-06-30: Entity Public Float $11.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $21.40M 10-K · filed 2026-03-30 |
| 2024-06-28 | $31.80M 10-K · filed 2025-04-03 |
| 2023-12-31 | $103.70M 10-K · filed 2024-04-15 |
| 2022-06-30 | $11.20M 10-K · filed 2023-03-30 |
| 2021-06-30 | $41.40M 10-K · filed 2022-03-15 |
| 2020-06-30 | $33.50M 10-K/A · filed 2021-05-07 |
| 2019-08-30 | $59.06M 10-K · filed 2020-05-04 |
| 2018-08-31 | $63.73M 10-K · filed 2019-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |